Psoriatic Arthritis (PsA) Treatment Market size is

Dubai, United Arab Emirates, January 19, 2022 (GLOBE NEWSWIRE) – World sales Psoriatic arthritis (PsA) treatment market set to higher 10.3 billion US dollars In 2022. We are expanding healthily 7.1% compound annual growth rate, the total market size is expected to reach 15.6 billion US dollars by 2028.

the Psoriatic arthritis (PsA) treatment market He is expected to sign up 7.1% Compound annual growth rate between 2022 and 2028, up from 6.7% The compound annual growth rate recorded during the period 2013-2021, forecasts future market insights.

Approximately 70% of patients with psoriasis are at risk of developing psoriatic arthritis, and up to 20% of patients with osteoarthritis are at risk of developing psoriasis, according to recent findings by the Arthritis Foundation.

Describe details
Estimated Psoriatic Arthritis (PsA) Treatment Market Size
10.3 USD
Psoriatic arthritis (PsA) treatment based on market value
CAGR (2022-2028)
~ 7.1%
Psoriatic Arthritis (PsA) Treatment Market Size Forecast
15.6 USD

Request a sample report to get comprehensive insights into

The increasing burden of psoriasis and psoriatic arthritis on the healthcare industry has boosted clinical research in the field of psoriatic arthritis, in recent years.

The continued adoption of conventional disease-modifying antirheumatic drugs (DMARDs), especially in cost-sensitive areas, is expected to increase the demand for psoriatic arthritis treatment in the coming years.

The role of strong product pipelines and increased clinical research investment

More than 20 psoriasis and psoriatic arthritis drugs are currently in phase 2 of the pipeline, while more than 28 are in phase III clinical trials, the National Psoriasis Foundation notes. However, about two dozen drugs have already received FDA approval for inclusion in the treatment of psoriasis and psoriatic arthritis.

While this robust product pipeline continues to drive demand for psoriasis and psoriatic arthritis treatments, new research indicates a shift in the focus of many drug manufacturers to competitive pricing strategies, in an effort to achieve widespread acceptance in the coming years. Recently, Future Market Insights released new intelligence based on analysis of the global psoriatic arthritis treatment market. The study forecasts robust annual growth of over 7% for the market in 2022.

For any inquiries related to the report, ask @analyst

Report scope

Describe details
prediction period 2013-2021
Historical data
available for me
Units for volume and $1 billion for value
Main areas
North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa.
Major countries
United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Italy, Spain, North, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, other countries .
market key
Product, management path, distribution channel, and region
• Pfizer Inc

• Johnson & Johnson

• AbbVie Inc.

• Amgen Inc.

• Bristol-Myers Squibb Company


• Eli Lilly & Co.

• Novartis AG

• Celgene Company

• AstraZeneca PLC

Industrial giants cover more than 55% of the market value share

In a fairly standardized global landscape of the psoriatic arthritis treatment market, more than 55% of total revenue is accounted for by industry giants such as Novartis AG and AbbVie Inc. Which includes pharmaceuticals in its core portfolio. While market leaders maintain the focus on FDA approvals and clinical trials, research also points to the growing importance of diversified pricing strategies.

Furthermore, the prominent players in the psoriatic arthritis treatment market are likely to increase investments in research and development of biosimilars, biopharmaceuticals, and tumor necrosis factor (TNF) inhibitors to target regional markets. A number of leading drug manufacturers are also maintaining significant investments in DMARDs due to enter the market in the next few years. This is seen as a strong factor improving the growth prospects of the psoriatic arthritis treatment market, according to the report.

Besides all this, strategic acquisitions, partnerships, and collaborations will continue to be the preferred expansion strategies adopted by the majority of prominent operators in the psoriatic arthritis treatment landscape,” says one of the company’s senior research analysts.

We provide tailor-made solutions to suit your requirements, customization request @

Increasing demand for biopharmaceuticals and DMARDs

A research-based understanding of the pathophysiology of psoriatic arthritis fuels the introduction of innovative therapies into the psoriatic arthritis treatment market, leading to innovations among market participants—and thus supporting the growth of the psoriatic arthritis treatment market. Targeted biological therapy has shown a decent success rate in terms of inducing temporary relief of psoriatic arthritis pain and thus continues to represent an attractive niche in the psoriatic arthritis treatment market.

The report says that the demand for biopharmaceuticals accounts for more than 55% of the global market revenue, while the demand for DMARDs makes up for more than 3/4y of the total market value. Although the majority of psoriatic arthritis patients choose injection as the preferred method of giving psoriatic arthritis treatment, the increased introduction of innovative oral medications is raising the popularity of oral psoriatic arthritis treatment.

The development of new oral treatments for psoriatic arthritis is likely to help the North American market grow. The increasing availability of combination therapies and relatively economical biosimilar therapies have been identified as the primary growth enhancers for the European market. Collectively, North America and Europe account for more than 60% of the global value of the psoriatic arthritis treatment market. The report indicates that the psoriatic arthritis market in Asia Pacific is likely to show high growth potential in the course of the next few years.

Buy [email protected]

Discover ongoing comprehensive coverage of FMI for healthcare

Traumatic Brain Injury (TBI) Treatment Market Every year, TBI contributes to a large number of cases worldwide. Traumatic brain injury can be defined as an injury to the brain resulting from an external trauma that damages brain cells and blood vessels.

Allergy Treatment Market – Allergies are the increased sensitivity of the immune system. Allergies occur when a naturally harmless foreign substance interacts with the immune system. These foreign substances are called allergens.

Substance use disorder treatment market – According to the World Health Organization (WHO), the leading cause of disability worldwide is not a physical illness, but a serious mood disorder known as depression. About 350 million people worldwide suffer from depression, and only about 50% of those will receive treatment.

Pediatric Sports Injury Treatment Market – The key factor for the growth of the global Pediatric Sports Injury Market is the increase in accidents during practice or during performance as the number of children participating in sports activities every year from all age groups increases.

Schizophrenia Treatment Market – The schizophrenia treatment market is primarily driven by the increasing prevalence of schizophrenic disorders due to change in lifestyle, extensive research and development, and increase in various addictions such as alcohol, drugs, etc.

Hepatocellular carcinoma (HCC) market – Hepatocellular carcinoma (HCC) is also known as hepatocellular carcinoma. Hepatocellular carcinoma (HCC) is the main malignancy of the liver and has been found mainly in patients with chronic liver disease and cirrhosis.

Glioblastoma Therapeutic Drug Market – Brain tumors are one of the major causes of cancer and are common among children and adolescents. Glioblastomas (GBM) are the most common grade IV tumor, which is malignant and contains dead tumor cells.

Brain Tumor Treatment Market – A brain tumor is an abnormal and uncontrolled proliferation of cells in the brain. It may be benign or malignant. A brain tumor arises from brain tissue and rarely spreads. The tumor eventually compresses and damages other structures in the brain.

Carcinoid Diarrhea Treatment Market – The carcinoid diarrhea treatment market will grow during the forecast years as many multinational companies focus on new product innovations in the treatment of carcinoid diarrhea.

Radioimmunotherapy market – According to Word Health, it is estimated that by 2030, around 23.6 million new cases of cancer will prevail worldwide. Governmental guidelines from the American Society of Clinical Oncology and the National Comprehensive Cancer Network (NCCN/ASCO) provide assistance to health care professionals in the management and treatment of patients with cancer.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market information and advisory services, serving clients in more than 150 countries. FMI is headquartered in Dubai, with delivery hubs in the UK, US and India. The latest market research and industry analysis reports from FMI help companies face challenges and make critical decisions with confidence and clarity amidst intense competition. Our customized and syndicated market research reports provide actionable insights that drive sustainable growth. FMI’s expert-led team of analysts constantly track emerging trends and events in a wide range of industries to ensure our clients are prepared for the evolving needs of their clients.


future market insights,
1602-6 Jumeirah Bay Tower X2,
Part Number: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
The United Arab Emirates
For sales inquiries: [email protected]
For media inquiries: [email protected]
Press release source:


Leave a Comment